OrbusNeich Medical Group Holdings Limited

SEHK:6929 株式レポート

時価総額:HK$3.1b

OrbusNeich Medical Group Holdings マネジメント

マネジメント 基準チェック /34

現在、CEO に関する十分な情報がありません。

主要情報

David Chien

最高経営責任者

US$1.0m

報酬総額

CEO給与比率79.8%
CEO在任期間8yrs
CEOの所有権n/a
経営陣の平均在職期間5.8yrs
取締役会の平均在任期間3.2yrs

経営陣の近況

Recent updates

Some Confidence Is Lacking In OrbusNeich Medical Group Holdings Limited (HKG:6929) As Shares Slide 28%

Jul 19
Some Confidence Is Lacking In OrbusNeich Medical Group Holdings Limited (HKG:6929) As Shares Slide 28%

OrbusNeich Medical Group Holdings Limited (HKG:6929) Shares Could Be 39% Below Their Intrinsic Value Estimate

Jul 03
OrbusNeich Medical Group Holdings Limited (HKG:6929) Shares Could Be 39% Below Their Intrinsic Value Estimate

Is OrbusNeich Medical Group Holdings (HKG:6929) A Risky Investment?

May 28
Is OrbusNeich Medical Group Holdings (HKG:6929) A Risky Investment?

Optimistic Investors Push OrbusNeich Medical Group Holdings Limited (HKG:6929) Shares Up 27% But Growth Is Lacking

May 06
Optimistic Investors Push OrbusNeich Medical Group Holdings Limited (HKG:6929) Shares Up 27% But Growth Is Lacking

OrbusNeich Medical Group Holdings' (HKG:6929) Earnings Are Weaker Than They Seem

Apr 25
OrbusNeich Medical Group Holdings' (HKG:6929) Earnings Are Weaker Than They Seem

Some Confidence Is Lacking In OrbusNeich Medical Group Holdings Limited (HKG:6929) As Shares Slide 26%

Mar 13
Some Confidence Is Lacking In OrbusNeich Medical Group Holdings Limited (HKG:6929) As Shares Slide 26%

Returns At OrbusNeich Medical Group Holdings (HKG:6929) Appear To Be Weighed Down

Feb 04
Returns At OrbusNeich Medical Group Holdings (HKG:6929) Appear To Be Weighed Down

A Look At The Intrinsic Value Of OrbusNeich Medical Group Holdings Limited (HKG:6929)

Oct 20
A Look At The Intrinsic Value Of OrbusNeich Medical Group Holdings Limited (HKG:6929)

Some OrbusNeich Medical Group Holdings Limited (HKG:6929) Shareholders Look For Exit As Shares Take 28% Pounding

Jun 01
Some OrbusNeich Medical Group Holdings Limited (HKG:6929) Shareholders Look For Exit As Shares Take 28% Pounding

CEO報酬分析

OrbusNeich Medical Group Holdings の収益と比較して、David Chien の報酬はどのように変化したか?
日付総報酬給与会社業績
Jun 30 2024n/an/a

US$39m

Mar 31 2024n/an/a

US$42m

Dec 31 2023US$1mUS$808k

US$45m

Sep 30 2023n/an/a

US$40m

Jun 30 2023n/an/a

US$36m

Mar 31 2023n/an/a

US$27m

Dec 31 2022US$1mUS$769k

US$18m

Sep 30 2022n/an/a

US$9m

Jun 30 2022n/an/a

US$272k

Mar 31 2022n/an/a

-US$2m

Dec 31 2021US$355kUS$326k

-US$4m

Dec 31 2020US$335kUS$320k

US$7m

Dec 31 2019US$336kUS$308k

US$7m

報酬と市場: Davidの 総報酬 ($USD 1.01M ) は、 Hong Kong市場 ($USD 398.33K ) の同規模の企業の平均を上回っています。

報酬と収益: Davidの報酬は、過去 1 年間の会社の業績と一致しています。


CEO(最高経営責任者

David Chien (59 yo)

8yrs

在職期間

US$1,012,000

報酬

Mr. David Chien serves as Chairman of the Board of OrbusNeich Medical Group Holdings Limited and serves as its Chief Executive Officer since November 11, 2016. Mr. Chen has served as Director of OrbusNeic...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
David Chien
Chairman of the Board & CEO8yrsUS$1.01mデータなし
Wing Shing Chen
CFO, Company Secretary & Executive Director6.8yrsUS$569.00kデータなし
Kwai Ching Lau
COO & Executive Director4.2yrsUS$702.00kデータなし
Alain Djamel Khair
Chief Commercial Officer4.8yrsデータなしデータなし

5.8yrs

平均在職期間

51yo

平均年齢

経験豊富な経営陣: 6929の経営陣は経験豊富で経験豊富です(平均在職期間は5.8年)。


取締役

名称ポジション在職期間報酬所有権
David Chien
Chairman of the Board & CEO3.3yrsUS$1.01mデータなし
Wing Shing Chen
CFO, Company Secretary & Executive Director3.3yrsUS$569.00kデータなし
Kwai Ching Lau
COO & Executive Director3.3yrsUS$702.00kデータなし
Yip Keung Chan
Independent Non-Executive Director3.2yrsUS$31.00kデータなし
Yi Zhou
Non-Executive Director3.2yrsデータなしデータなし
Ka Keung Lau
Independent Non-Executive Director3.2yrsUS$31.00kデータなし
Lai Fan Tam
Independent Non-Executive Director3.2yrsUS$31.00kデータなし
Ching Chung Chow
Non-Executive Director3.3yrsUS$279.94k0.037%
HK$ 1.2m
Ting San Leung
Non-Executive Director1.5yrsUS$19.00kデータなし

3.2yrs

平均在職期間

49yo

平均年齢

経験豊富なボード: 6929の 取締役会経験豊富 であると考えられます ( 3.2年の平均在任期間)。